Ulcerative Colitis Clinical Trial
Official title:
A Comparison Of High Definition White Light And High Definition Virtual Chromoendoscopy For The Detection Of Intraepithelial Neoplasia In Longstanding Colitis: A Randomised Controlled Trial
Colitis is inflammation of the large bowel and it is often caused by conditions known as
ulcerative colitis and Crohn's disease. In these conditions, the body has an exaggerated
inflammatory response against the bowel - the body attacks the bowel. Patients who have had
colitis affecting most of the large bowel for more than 8 years are at increased risk of
cancer of the large bowel. In view of this, many national gastroenterology organisations have
recommended that such patients have regular colonoscopies to detect pre-cancerous areas and
even early cancer in the large bowel. Early detection of such areas, will lead to early
treatment thereby reducing the risk of developing significant large bowel cancer. These
regular colonoscopies are known as surveillance colonoscopies.
Official international guidelines for surveillance in patients with ulcerative and Crohn's
colitis advise to take 4 random samples of large bowel tissue (biopsies) every 10 centimeters
and of any suspicious areas. Recent studies have shown that spraying dye such as indigo
carmine (a type of food dye) helps highlight abnormal areas that could harbor pre-cancerous
cells. This technique is time-consuming, and tedious. There are no set standards of what is
considered a satisfactorily completed dye spray colonoscopy. The uptake of this technique in
the UK has not been uniform. Therefore virtual chromoendoscopy has been studied as an
alternative method to improve the detection of pre-cancerous tissue in patients with
longstanding colitis.
Virtual chromoendoscopy systems enhances specific characteristics of the lining of the large
bowel such as surface patterns and mucosal vasculature. This theoretically increases the
detection of pre-cancerous tissue compared to high definition white light endoscopy alone.
Narrow-band imaging or NBI (Olympus, Tokyo, Japan), Blue Laser (Fujinon, Tokyo, Japan) and OE
scan (Pentax, Tokyo, Japan) use optical light filters to select particular narrow spectrums
of red, green and blue light with a relative decrease in the proportion of red light. The
Fujinon Intelligent Chromo-Endoscopy (FICE) system uses post hoc computer algorithms,
applying different filters to the stored endoscopic images and enabling a theoretically
endless number of combinations of filters that can be used. The Pentax I-SCAN system also
allows post hoc modification of the images. It provides the ability to enhance the mucosal
surface to better highlight mucosal changes.
These new imaging techniques have a theoretical advantage, which is extendedly used for sales
purposes but so far has not been proven in the surveillance for precancerous or early cancer
of the large bowel in patients with longstanding colitis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05702879 -
Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
|
||
Not yet recruiting |
NCT05953402 -
A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
|
||
Recruiting |
NCT05316584 -
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy
|
N/A | |
Recruiting |
NCT03950232 -
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
|
Phase 3 | |
Completed |
NCT03124121 -
Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels
|
Phase 4 | |
Not yet recruiting |
NCT06100289 -
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
|
Phase 3 | |
Withdrawn |
NCT04209556 -
A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis
|
Phase 2 | |
Terminated |
NCT00061282 -
Clotrimazole Enemas for Pouchitis in Children and Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT04398550 -
SCD vs. Mediterranean Diet Therapy in Ulcerative Colitis
|
N/A | |
Recruiting |
NCT04314375 -
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
|
Phase 4 | |
Active, not recruiting |
NCT04857112 -
Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis
|
Phase 2 | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Active, not recruiting |
NCT04033445 -
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
|
Phase 2/Phase 3 | |
Recruiting |
NCT05428345 -
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
|
||
Active, not recruiting |
NCT06221995 -
Energy Expenditure in Patients With Ulcerative Colitis Undergoing Surgery
|
||
Recruiting |
NCT04767984 -
Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis
|
Phase 2 | |
Completed |
NCT02508012 -
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
|
N/A | |
Recruiting |
NCT06071312 -
FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach
|
Phase 1/Phase 2 | |
Completed |
NCT03760003 -
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
|
Phase 2 | |
Not yet recruiting |
NCT05539625 -
Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis
|
Phase 2 |